Health Technology Assessment (HTA)
Health Technology Assessment (HTA) is a multidisciplinary process that uses explicit methods to determine a health technology’s value for healthcare decision-making. Attitudes towards HTA vary globally, with some countries using a variety of methods and analyses and others hardly any.
Advances in Oncology Modelling: Recent Results from POI Research
18 September 2012
OHE and the Pharmaceutical Oncology Initiative (POI) held a workshop to discuss and debate several key issues in oncology modelling. Participating were more than 50 experts…
Spotlight on OHE: Recent Awards, Publications and Presentations
12 September 2012
This post reviews selected external OHE activities and publications from the past three months.
OHE Awarded £457K Grant on Measuring Public Preferences for Health States
2 August 2012
OHE’s Prof Nancy Devlin and Prof Ben van Hout of the University of Sheffield have been awarded a £457,000 grant from the Policy Research Programme (PRP)…
Spotlight on OHE: Development and Use of Measures of Health Worldwide
16 July 2012
OHE team members have been active in a number of external seminars, conferences and workshops. These included gatherings of academic experts, discussions involving governments, and meetings…
Prospective Observational Studies: Whether, When and How to Use
18 June 2012
OHE’s Adrian Towse is co-author on the recent report by the ISPOR Good Research Practices Task Force on assessing comparative effectiveness using prospective observational studies.
HTAinSite: Recent Changes in the Database of NICE Decisions
7 June 2012
HTAinSiteImagine being able to find, in ONE minute or less, which NICE Technology Assessments (TAs) make specific reference to QALY thresholds of £20,000 or £30,000, for…
NICE’s Social Value Judgments: A Closer Look at Progress
30 May 2012
Now out as a “FirstView” article in Health Economics, Policy and Law is an important analysis on the inclusion of social value judgments in NICE guidance,…
Time Trends in NICE HTA Decision Making: Setting the Record Straight
21 May 2012
The Daily Mail front page article of 16 May 2012, ‘New cancer drugs held up by the NHS for nine years’ purports to draw, as its…
Overview of the Economics of the Market for Medicines in the UK
29 March 2012
OHE’s Dr Jorge Mestre-Ferrandiz is a visiting lecturer in the Department of Economics at City University London. As part of his 2012 activities, he recently gave…